Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study.
Saved in:
| Title: | Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study. |
|---|---|
| Authors: | Rutgeerts, P.1 (AUTHOR), Lemmens, L.1 (AUTHOR), Van Assche, G.1 (AUTHOR), Noman, M.1 (AUTHOR), Borghini‐Fuhrer, I.2 (AUTHOR), Goedkoop, R.2 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jan2003, Vol. 17 Issue 2, p185-192. 8p. 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1046/j.1365-2036.2003.01414.x |
